Navigation Links
Thyroid in Medical Technology
... (SNPs) conferring substantial
increased risk of thyroid cancer. The two SNPs, located on chromosomes ... SNPs, putting them at a 5.7-times greater risk of thyroid cancer than
individuals who carry no copies of ... and they associate with
altered levels of key thyroid hormones.
"This is an important discovery ...
... cancer research, Dallas, TX. (abstract #8014). thyroid Cancer A Phase 2 Study of Sorafenib in Metastatic thyroid Carcinoma Findings from this single-arm Phase 2 ... partial responses) in patients with advanced thyroid cancer. In the study, Nexavar was well-tolerated; ...
... in patients with medullary thyroid cancer- SAN FRANCISCO, Oct. 23 ... the cutoff. Of seven patients with medullary thyroid cancer (MTC), three have had partial responses ... a marker frequently elevated in medullary thyroid cancer, and six of the seven patients had a ...
... -- Doctors often mistake the symptoms of thyroid disease for another disorder such as heart ... from Harvard Medical School. The symptoms of thyroid diseases are so wide-ranging, particularly in older men and women, that doctors often overlook thyroid disorder as the cause and instead focus on ...
... with other anti-cancer therapies in a range of tumor types, including thyroid cancer. Results from the ZEPHYR (300mg monotherapy study in EGFR ... NSCLC, Phase III) and ZETA (300 mg monotherapy in advanced medullary thyroid cancer, Phase III) studies will be available during the second half of ...
... mimic the activity of TSH, leading to an elevated production of thyroid hormone. Left untreated, Graves' disease can lead to miscarriage, birth defects, thyroid eye disease and can be life-threatening. Studies have shown that the ...
... weight loss (including gastric bypass surgery), the death of a loved one, starting or stopping oral contraceptives, iron deficiency, and chronic thyroid diseases can trigger this type of hair loss. "When I evaluate patients' hair and their recent medical history, I am able to determine if their ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
... endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. For more information, please call the AACE ...
... (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, ...
... (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, ...
... that is in Phase 2 as an oral treatment for the symptoms of secondary hypogonadism and other conditions in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel Vitamin D analogue, is in Phase 2 clinical ...
... endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. For more information, please call the AACE ...
... occur on their own, independent of other health concerns. Or anxiety can be a symptom of several health conditions, such as heart or lung disease, thyroid problems -- even dietary problems. Treating the underlying condition can help reduce or manage the anxiety. When anxiety is the primary concern, ...
... investigator of the ATHENA trial said "The clinical benefits observed with dronedarone in ATHENA occurred without a significantly higher rate of thyroid or pulmonary disorders compared with placebo reported within the study period." About the ATHENA Study The landmark ATHENA study is the ...
... (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
... after seven days. Values returned to baseline within one week after treatment discontinuation with no impact on renal function. No evidence of thyroid or pulmonary fibrosis was observed with dronedarone and no Torsade de Pointes was reported during the six-month follow-up. ERATO (The Efficacy and ...
... (low white blood cell count), thrombocytopenia (low platelet count) and neutropenia (low neutrophil count); thyroiditis (inflammation of the thyroid gland); and autoimmunity (production of antibodies against the body's own tissues). About Peg-IFN Interferon is a protein produced naturally by ...
... potassium and sodium channels and has anti-adrenergic properties. Dronedarone does not contain the iodine radical and did not show any evidence of thyroid or pulmonary toxicity in clinical trials. About sanofi-aventis in Cardiology and Thrombosis Sanofi-aventis' unmatched experience in the treatment ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
... and Transferrin testing by nephelometric methodology. The Dimension Vista Intelligent Lab system menu offers panels for anemia, cardiac disease, thyroid disorders, therapeutic drug monitoring, protein testing, drugs-of-abuse testing, and routine and specialty chemistry testing. About Siemens ...
... either alone or in combination with standard chemotherapy (docetaxel). (1)(2) Vandetanib is also being evaluated as a treatment option in medullary thyroid cancer and has been awarded Food and Drug Administration (FDA) orphan drug status and fast track designation for this indication. About ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
... cancer research, Dallas, TX. (abstract #8014). thyroid Cancer A Phase 2 Study of Sorafenib in Metastatic thyroid Carcinoma Findings from this single-arm Phase 2 ... partial responses) in patients with advanced thyroid cancer. In the study, Nexavar was well-tolerated; ...
Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO
... in Patients with Medullary thyroid Cancer CHICAGO, June 1 /PRNewswire-FirstCall/ ... and radiotherapy. "Patients with medullary thyroid cancer are a highly underserved population as ... multiforme are ongoing. About Medullary thyroid Cancer The American Cancer Society estimates ...'Second Thoughts about Fluoride,' Reports Scientific American
... teeth, bones, the brain and the thyroid gland," reports Scientific American editors ... alter endocrine function, especially in the thyroid -- the gland that produces hormones regulating ... who chaired the NRC committee thusly, "The thyroid changes do worry me." Fluoride in foods, ...... in patients with medullary thyroid cancer- SAN FRANCISCO, Oct. 23 ... the cutoff. Of seven patients with medullary thyroid cancer (MTC), three have had partial responses ... a marker frequently elevated in medullary thyroid cancer, and six of the seven patients had a ...
... -- Doctors often mistake the symptoms of thyroid disease for another disorder such as heart ... from Harvard Medical School. The symptoms of thyroid diseases are so wide-ranging, particularly in older men and women, that doctors often overlook thyroid disorder as the cause and instead focus on ...
... with other anti-cancer therapies in a range of tumor types, including thyroid cancer. Results from the ZEPHYR (300mg monotherapy study in EGFR ... NSCLC, Phase III) and ZETA (300 mg monotherapy in advanced medullary thyroid cancer, Phase III) studies will be available during the second half of ...
... mimic the activity of TSH, leading to an elevated production of thyroid hormone. Left untreated, Graves' disease can lead to miscarriage, birth defects, thyroid eye disease and can be life-threatening. Studies have shown that the ...
... weight loss (including gastric bypass surgery), the death of a loved one, starting or stopping oral contraceptives, iron deficiency, and chronic thyroid diseases can trigger this type of hair loss. "When I evaluate patients' hair and their recent medical history, I am able to determine if their ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
Type 2 Diabetes: An Epidemic Among America's Youth
... endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. ...Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient
... endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. ...... endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. For more information, please call the AACE ...
Methadone Frequently Causes Menopausal Symptoms in Young Women
... replacement, vitamin and mineral supplementation. Florida Detox and Wellness Institute tests and treats estradiol, progesterone, testosterone, thyroid and dehydroepiandrosterone, DHEA, hormone deficiencies, caused by opiate pain medication. Clinical research by Florida Detox and Wellness ...... (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, ...
... (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, ...
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
... permitted approvability. Finally, the Advisory Committee unanimously supported approvability of liraglutide with regard to risk of papillary thyroid cancer. "We remain convinced that liraglutide has a positive benefit/risk profile and represents an important advance for people ...... that is in Phase 2 as an oral treatment for the symptoms of secondary hypogonadism and other conditions in men. Sobetirome, a novel, selective thyroid receptor beta agonist, is in Phase 1 as a potential treatment for dyslipidemia. Becocalcidiol, a novel Vitamin D analogue, is in Phase 2 clinical ...
... endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity. For more information, please call the AACE ...
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...... occur on their own, independent of other health concerns. Or anxiety can be a symptom of several health conditions, such as heart or lung disease, thyroid problems -- even dietary problems. Treating the underlying condition can help reduce or manage the anxiety. When anxiety is the primary concern, ...
... investigator of the ATHENA trial said "The clinical benefits observed with dronedarone in ATHENA occurred without a significantly higher rate of thyroid or pulmonary disorders compared with placebo reported within the study period." About the ATHENA Study The landmark ATHENA study is the ...
... (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
... is one of the most frequently mutated members of the kinase family across all cancers, and is particularly common in malignant melanomas, colon, and thyroid cancers. The V600E mutant form of BRAF kinase in particular has been associated with increased tumor aggressiveness and decreased survival rates in ...... after seven days. Values returned to baseline within one week after treatment discontinuation with no impact on renal function. No evidence of thyroid or pulmonary fibrosis was observed with dronedarone and no Torsade de Pointes was reported during the six-month follow-up. ERATO (The Efficacy and ...
Prescription Sleeping Pill Use Tied to Cancer
... that took sleeping pills compared to none in the placebo groups. Lab animals given high doses of hypnotic drugs are known to have developed kidney, thyroid and testicular cancers and suffer chromosome damage, which is a sign of carcinogenicity. Although a direct causal link between cancer and sleeping ...Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
... potassium and sodium channels and has anti-adrenergic properties. Dronedarone does not contain the iodine radical and did not show any evidence of thyroid or pulmonary toxicity in clinical trials. About sanofi-aventis Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and ...... (low white blood cell count), thrombocytopenia (low platelet count) and neutropenia (low neutrophil count); thyroiditis (inflammation of the thyroid gland); and autoimmunity (production of antibodies against the body's own tissues). About Peg-IFN Interferon is a protein produced naturally by ...
ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
... potassium and sodium channels and has anti-adrenergic properties. Dronedarone does not contain the iodine radical and did not show any evidence of thyroid or pulmonary toxicity in clinical trials. Based upon this new clinical data, sanofi-aventis plans to submit a registration dossier to the European ...ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
... potassium and sodium channels and has anti-adrenergic properties. Dronedarone does not contain the iodine radical and did not show any evidence of thyroid or pulmonary toxicity in clinical trials. Based upon the new ATHENA clinical data, sanofi-aventis plans to submit a registration dossier to the ...PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C
... (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, ...... potassium and sodium channels and has anti-adrenergic properties. Dronedarone does not contain the iodine radical and did not show any evidence of thyroid or pulmonary toxicity in clinical trials. About sanofi-aventis in Cardiology and Thrombosis Sanofi-aventis' unmatched experience in the treatment ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
... and Transferrin testing by nephelometric methodology. The Dimension Vista Intelligent Lab system menu offers panels for anemia, cardiac disease, thyroid disorders, therapeutic drug monitoring, protein testing, drugs-of-abuse testing, and routine and specialty chemistry testing. About Siemens ...
Roche responds to announcement of 'IDEAL' hepatitis C trial results
... (hypertension, supraventricular arrhythmias and myocardial infarction), hypersensitivity (including anaphylaxis), endocrine disorders (including thyroid disorders and diabetes mellitus), autoimmune disorders (including idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, ...Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
... as of the June 22, 2007 cutoff; further data were also provided for six additional patients after the cutoff. Of seven patients with medullary thyroid cancer (MTC), three had partial responses (two confirmed and one unconfirmed) as of the date of the AACR-NCI- EORTC Conference. In addition, as of ...... either alone or in combination with standard chemotherapy (docetaxel). (1)(2) Vandetanib is also being evaluated as a treatment option in medullary thyroid cancer and has been awarded Food and Drug Administration (FDA) orphan drug status and fast track designation for this indication. About ...
... child has advanced disease of the blood vessels (arteriosclerosis); symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland (hyperthyroidism); known allergy or unusual reactions to drugs called sympathomimetic amines (for example, pseudoephedrine); seizures; ...
Other ContentsOther TagsOther Tags
(Date:6/19/2013)... provider of scientific, technical and medical information products and ... new open access journal, GeoResJ . , ... and planetary science journals portfolio has its first open ... forum for rapid publication of top research within the ... by six Executive Editors, each covering a different discipline, ...
(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...
(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4(Date:6/19/2013)... Brain not working? Functional medicine pioneer Datis ... minor brain problems as brain fog, memory loss, fatigue, ... indicate the brain may be degenerating—or aging—too quickly, raising ... and other neurological diseases. Why Isn’t My Brain ... is now available online at Amazon and ...
(Date:6/19/2013)... Chrysler made news recently when it refused to accept ... The Jeep models in question are the 1993-2004 Jeep Grand ... NHTSA are vulnerable to fire and explosion in a crash. ... and have been alleged to catch fire or explode upon ... 32 rear-end crashes, which resulted in 44 deaths and the ...
(Date:6/19/2013)... 2013 Citi Bike has come to New York ... David Perna to know for sure how many patients will choose ... they’ll have the option. In fact, he’s happy about anything ... also make it more convenient for them to visit his office ... of Complimentary Alternative Medicine at Back and Body Medical and an ...
(Date:6/19/2013)... Lawrence, KS (PRWEB) June 19, 2013 ... photographs is common with today’s computer software, it creates ... a form of misconduct. As an already published case ... of photo manipulation. , The Journal of Parasitology ... image manipulation in a 2004 article published in ...
(Date:6/19/2013)... LOS ANGELES (June 19, 2013) In what is ... with the most common form of hereditary dystonia ... experts in deep brain stimulation report good success ... director of the Movement Disorders Program at Cedars-Sinai Medical ... chief of the Division of Neurosurgery at Beth Israel ...
Breaking Medicine News(10 mins):Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 3Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2[0] Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later[0] Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent[0] New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan[0] Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines[0] Long-term study reports deep brain stimulation effective for most common hereditary dystonia
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |